MARKSANS PHARMA LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 264.25 INR | +2.28% |
|
+9.32% | +64.54% |
| Aug. 21 | Marksans Pharma Arm Gets UK Regulator's Marketing Nod for Fluoxetine Capsules | MT |
| Aug. 20 | Marksans Pharma Gets US FDA's EIR for Goa, India Unit | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MARKSANS PHARMA LIMITED | Other Pharmaceuticals | +2.28% | +9.32% | +64.54% | +150.08% | +1,501.69% | 1.42B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- MARKSANS Stock
- Charts Marksans Pharma Limited
- Comparison Chart